What is Axokine?
Initially developed to treat ALS or Lou Gehrig’s disease, Axonine was retooled as a weight loss product after it was clinically found to produce a loss of appetite in test subjects. However, after heavily reported studies in 2003 found that the drug was apparently incapable of yielding substantial weight loss results, Axokine’s parent company gave up and put a stop to its plans to produce the drug. To this day, Axokine is unavailable in either prescription form or over the counter.










